US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
All News
Headline News
Barchart.com
Benzinga
BreakingCrypto
Chartmill
Finterra
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
MarketMinute
PredictStreet
StockStory
Stocktwits
Talk Markets
TokenRing AI
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Actusnews Wire
Authority Press Wire
B2i Digital
Brandpoint
BusinesNews Wire
Business Wire
CannabisNewsWire
CryptoCurrencyWire
FinancialNewsMedia
First Publisher
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
NewMediaWire
Newsfile
NewsUSA
Newswire.com
PR Underground
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
PulseBulletin.com
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
TheNewswire
Visibility
Worldnewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Canon Medical Systems USA, Inc. announces Ultimion photon-counting CT system at RSNA 2026
November 20, 2026
From
Canon Medical Systems USA
Via
GlobeNewswire
NuCana Presents Preclinical Data Showing NUC-7738 Enhances Carfilzomib Activity in Multiple Myeloma Cell Lines at the 38th EORTC-NCI-AACR Symposium
November 20, 2026
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
ZJK Advances Its Aerospace Precision Components Business
November 20, 2026
From
ZJK Industrial Co., Ltd.
Via
GlobeNewswire
Tickers
ZJK
Allogene Therapeutics to Host Events at American Society of Hematology Annual Meeting 2026 Highlighting the Potential of Allogeneic CAR T to Expand Patient Access
November 20, 2026
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ALLO
LoJack by Solera Congratulates Kyle Larson and Hendrick Motorsports on Back-to-Back NASCAR Cup Series Championships
November 20, 2026
From
Solera Global Corp.
Via
GlobeNewswire
BILL Shareholder Alert: Ademi LLP Investigates Whether Buyout Fairly Values BILL Holdings, Inc.
November 20, 2026
From
Ademi LLP
Via
GlobeNewswire
Tickers
BILL
HeartSciences Shareholders Approve Proposed Business Combination with Fortitude Mining
November 20, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Tickers
HSCS
HSCSW
HeartSciences Shareholders Approve Business Combination with Fortitude
November 20, 2026
From
Fortitude Mining Holdings, Inc.
Via
GlobeNewswire
ProLogium Presents Battery Pack 2.0 at NASA Aerospace Battery Workshop for Space Missions and Lunar Infrastructure
November 20, 2026
From
ProLogium Technology Co., Ltd.
Via
GlobeNewswire
Hotel101 Global Enters Johor Bahru Malaysia
November 20, 2026
From
Hotel101 Global Holdings Corp
Via
GlobeNewswire
Tickers
HBNB
Carrier Connect Data Solutions Inc. Begins Trading on OTCQX Best Market
November 20, 2026
From
OTC Markets
Via
GlobeNewswire
Tickers
CCDSF
OTCM
TSX-V:CCDS.V
Bunker Hill-Backed Frontier Minerals Consortium Named Successful Bidder by Government of Kenya for Mrima Hill Rare Earth and Niobium Project
November 20, 2026
From
Bunker Hill Silver Corp.
Via
GlobeNewswire
Tickers
AREC
BHLL
TSX:BNKR
Overseas Revenue Up 171.5% YoY, Contributing Nearly Half of Total Revenue; Record High Quarterly Robotaxi Revenue of Over RMB100 Million; Third Quarter 2026 Revenue of RMB321.5 Million, Up 88.0% YoY; Gross Margin Reached 43.0%
November 20, 2026
From
WeRide Inc.
Via
GlobeNewswire
Tickers
WRD
Bullish attains SOC 1 Type 2 and SOC 2 Type 2 compliance
November 20, 2026
From
Bullish
Via
GlobeNewswire
Tickers
BLSH
BitFuFu Reports Unaudited Third Quarter 2026 Financial Results
November 20, 2026
From
BitFuFu Inc.
Via
GlobeNewswire
Tickers
FUFU
LyondellBasell announces quarterly dividend
November 20, 2026
From
LyondellBasell
Via
GlobeNewswire
Tickers
LYB
GE Aerospace Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited
November 20, 2026
From
GE Aerospace
Via
GlobeNewswire
Tickers
GE
Prospect Capital Announces SFS Exit With a 41.8% Realized IRR and 1.2x Multiple of Invested Capital
November 20, 2026
From
Prospect Capital Corporation
Via
GlobeNewswire
Tickers
PSEC
Bath & Body Works and Pantone Launch a Limited-Edition Fragrance Collection for the Holidays
November 20, 2026
From
Bath & Body Works, Inc.
Via
GlobeNewswire
Tickers
BBWI
Transaction in Own Shares
November 20, 2026
From
Shell plc
Via
GlobeNewswire
Tickers
SHEL
Leads Biolabs Presents Opamtistomig (PD-L1/4-1BB Bispecific Antibody) to Global Investors at the 2026 Jefferies Global Healthcare Conference
November 20, 2026
From
LEADS BIOLABS CO., LTD.
Via
GlobeNewswire
Sigenergy Earns Double BloombergNEF Tier 1 Recognition for Power Inverters and Energy Storage in Q4 2026
November 20, 2026
From
Sigenergy
Via
GlobeNewswire
U.S. Job Applicants Who Use AI Land Multiple Offers Twice as Often
November 20, 2026
From
Gdoc.io
Via
GlobeNewswire
Equinor ASA: Announcement of cash dividend of NOK 3.7448 per share for second quarter 2026
November 20, 2026
From
Equinor ASA
Via
GlobeNewswire
Rae Marie Homes Offers Whole-Property Planning for Luxury Estate Construction in the Black Hills
November 20, 2026
From
Rae Marie Homes
Via
GlobeNewswire
FRO – Third Quarter and Nine Months 2026 Results
November 20, 2026
From
Frontline plc.
Via
GlobeNewswire
Vallourec Third Quarter 2026 Results
November 20, 2026
From
VALLOUREC
Via
GlobeNewswire
LEPAS L8, L6 and L4 Earn Five-Star Ratings in 2026 Euro NCAP Assessment
November 20, 2026
From
Chery Auto
Via
GlobeNewswire
OSL Group Publishes Executive Insight: Every Company Needs a Stablecoin Strategy
November 20, 2026
From
OSL Group
Via
GlobeNewswire
ADDEX THERAPEUTICS TO REPORT 2026 THIRD QUARTER FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 25, 2026
November 20, 2026
From
Addex Therapeutics
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >